SUMMARY We evaluated scintigraphic techniques in estimating infarct size. In 26 patients with acute transmural myocardial infarction, "mTechnetium pyrophosphate (TcPYP) infarct scintigraphy, gated cardiac blood pool scintigraphy and 201-Thallium (201-TI) perfusion scintigraphy were performed. Invasive hemodynamic measurements were obtained and serial venous blood specimens taken for measurement of total and MB creatine phosphokinase (CPK). Infarct size was estimated from the area of abnormal TcPYP uptake, the extent of reduced 201-TI uptake, the percentage of abnormally contracting segments, and serial enzyme measurements. Left ventricular ejection fraction (LVEF) and stroke work index (LVSWI) were calculated.
IN RECENT YEARS, considerable interest has centered on methods aimed at determining the extent of acute myocardial infarction. Until such methods are reliably established, it will remain difficult to assess the effects of therapeutic interventions designed to reduce or minimize myocardial damage and thus improve prognosis after infarction.
99mTechnetium pyrophosphate (TcPYP) scintigraphy is a sensitive and relatively specific indicator of the presence of acute infarction.1 2 Experimental studies have shown good correlation between acute infarct size as judged from the area of abnormal myocardial uptake of radionuclide on the TcPYP scintigram and the extent of histologic infarction or gross infarct weight.3' We sought to assess the value of TcPYP scintigraphy in determining infarct size clinically, relating it to other scintigraphic techniques, enzymatic estimates of infarct size, and indices of left ventricular function.
Materials and Methods We studied 26 patients admitted to the Coronary Care Unit with acute transmural myocardial infarction (MI). The diagnosis of MI was based on the clinical history, serial electrocardiographic abnormalities with the development of Q waves > 0.04 sec, and serum MB creatine phosphokinase (CPK) elevation. Historical, electrocardiographic (ECG) and enzymatic evidence of prior infarction, as well as ECG evidence of left ventricular hypertrophy5 were sought.
Informed consent was obtained and the initial scintigrams and invasive hemodynamic measurements were carried out in the CCU within 72 hours of admission.
TcPYP infarct area was associated with the extent of reduced 201-TI uptake (r = 0.66), the percentage of abnormally contracting segments (r = 0.64), and with both LVSWI (r = -0.73) and LVEF (r = -0.58). TcPYP infarct area did not correlate with cumulative total or MB-CPK release or the integrated total CPK-time curve, nor did the enzyme estimates of infarct size correlate with LVSWI or LVEF.
Variable perfusion of infarcts of different sizes may explain the lack of correlation between TcPYP infarct area and enzyme estimates of infarct size. A combination of anatomic and functional indices derived from scintigraphic and hemodynamic measurements may provide the best assessment of infarct size.
Myocardial infarct scintigraphy was performed 24-48 hours after admission, following the intravenous administration of 15 mCi of TcPYP6 manufactured according to the method of Huberty and co-workers.7 Anterior, 450 left anterior oblique and left lateral projections, each taken to 300,000 counts, were obtained on Polaroid prints at least two hours after TcPYP administration using a portable Ohio Nuclear Series 120 or Searle Pho-Gamma IV scintillation camera with a high resolution collimator. TcPYP scintigrams were evaluated by two independent observers who had no knowledge of the clinical history or other laboratory findings. Scintigrams were graded on a scale of 0-4+ based on the level of radioactivity in the cardiac region: zero represented background activity; 1+ represented slight, indefinite increase in activity beyond background; 2 + represented definite increase in activity less intense than bone; 3 + represented activity equal to bone; and 4+ represented activity greater than bone. Scintigrams graded 2-4+ were called abnormal and the region of radionuclide localization was determined after evaluation of all projections. The observers agreed totally on the TcPYP area of abnormality in 19 of 26 patients with small regions of disagreement amounting to less than 10% of measured infarct size in the remaining seven patients. The area of involvement in the seven controversial cases was always clarified by discussion after review of the scintigrams in multiple projections. One observer reread all images two months after the initial reading and showed only minor discrepancies in three cases when compared to his original evaluation. The area of infarction was calculated by planimetry of the area of abnormal TcPYP activity for anterior infarcts, using the projection which demonstrated the largest area of involvement. For inferior infarcts, the product of linear measurements obtained from orthogonal projections (anterior and left lateral) was used. A radioactive grid source of known dimensions was used to provide a magnification correction factor for the scintigrams. The TcPYP infarct area thus obtained was expressed in absolute terms (cm2).
Gated No 2, FEBRUARY 1978 since no better correlation was obtained through exclusion of patients with large infarct areas (20 cm2 or more). Another important factor is that serial enzyme measurements provide an index of myocardial mass infarcted, rather than infarct area as estimated from the TcPYP scintigram, although exclusion of patients in our series with ECG evidence of left ventricular hypertrophy did not improve the correlation. None of our patients in whom complete CPK curves were obtained were subject to electrical defibrillation, and intramuscular injections were avoided in all patients. Thallium-201 and TcPYP imaging in the dog22 has shown that both techniques correlate with histologic estimates of infarct size. However, TcPYP scintigraphic abnormalities in corresponding projections were consistently larger than 201-T I perfusion defects. We found that for anterior infarcts the TcPYP abnormality was usually larger in the anterior projection where it was seen en face, whereas the 201-TI perfusion defect was largest in profile in the LAO or left lateral projection. Inferior infarcts were generally more comparable in corresponding projections of TcPYP and 201-TI scintigrams, being seen in profile with both techniques. An alternate explanation for the larger size of the TcPYP abnormality may relate to the presence of a kind of border zone with scattered necrosis and TcPYP uptake but also possessing a significant amount of viable, perfused myocardium. Superimposition of infarct and perfusion scintigrams did not demonstrate a classic underperfused, noninfarcted peri-infarction border zone as defined experimentally. 33 However, in a dual isotope study, Parke et al.34 did demonstrate some cases with 201-T1 defects greater than TcPYP abnormalities, suggesting a marginal, potentially reversible ischemic border zone. Nevertheless, it seems unlikely that demonstration of the border zone defined experimentally33 could be achieved by in vivo imaging using these techniques. The borders of the abnormal scintigraphic region are more difficult to delineate in the cold spot perfusion image than in the hot spot infarct image. Depending on the size and location of the perfusion defect and the projection used, surrounding normally perfused myocardium may make definition of the limits of the perfusion defect difficult or mask it altogether. On the other hand, some normal cardiac regions at the base and apex may show relatively diminished 201-TI uptake. For these reasons, we did not attempt quantitative assessment of the 201-Tl infarct image, but evaluated the scintigrams grossly and visually as generally performed and reported in the literature. '6' 35, 36 Additionally, visualization of perfusion defects following infarction appear to be time-dependent.37 Had we performed 201-T1 perfusion scintigraphy earlier, we might have seen larger defects. Nonetheless, the correlation of TcPYP infarct area with the overall extent of a 201-T1 perfusion defect as summated from all projections is supportive evidence that TcPYP infarct area is a valid estimate of infarct size. The gated cardiac blood pool scintigram and hemodynamic findings provided further anatomic and functional evidence for the validity of TcPYP infarct area as such an estimate.
We sought to evaluate the ability of the TcPYP infarct scintigram to size acute myocardial infarction in man and chose a study population optimal for that technique. The study has a high sensitivity and generally reveals intense, discrete abnormalities in patients with acute transmural infarction.1' 2 The scintigraphic findings and our results might differ in patients with subendocardial infarction or in a group of patients with a less clear clinical event.
We did not employ computer techniques in the analysis of 
